Impact BioMedical - IBO Earnings growth forecast for next year
Impact BioMedical Inc (IBO) ensures high margins by optimizing the supply of eco-components. The holding's revenues are based on licensing royalties from health protection patents. Investors remain cautious for now, awaiting the commercial success of the software. The GURU.Markets platform contains a prospective EPS growth vector for the coming year, where the current level equals 0.00, demonstrating an inflow of institutional capital.
Analytical breakdowns and data insights for company impactbiomedinc.com (IBO)
- price and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- debt and liquidity data:
- net income and valuation ratios data:
IBO - Company Net Income|Projected Future Earnings Impact BioMedical Inc|IBO - Business Payback Period|Future Price to Earnings Impact BioMedical Inc|IBO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Impact BioMedical|IBO - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Impact BioMedical|IBO - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth impactbiomedinc.com|IBO - Earnings per share growth this year|Earnings growth forecast for next year Impact BioMedical Inc
Comprehensive company analysis:Impact BioMedical Inc
For the biotech platform Impact BioMedical Inc (IBO), which develops antibacterial therapy in the B2B segment, the historical trend of the next-year EPS forecast reflects market confidence in the commercialization of its developments. This indicator aggregates expert consensus expectations regarding profit changes, allowing investors to assess the fundamental stability of the business model and the risks of revenue overvaluation amid volatility in the cost of borrowed capital.
Direct competitors
Net earnings per share growth forecast for next year Haleon Group|KVUE: Expected earnings per share trend next year|Earnings growth forecast for next year VRNA|Consensus forecast of earnings per share growth for next year jyongbio.com|Net earnings per share growth forecast for next year Ligand LGND|AMRX - Expected earnings per share growth for next year|PRGO - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year ALVO|LQDA: Earnings growth forecast for next year|glpg.com (GLPG) - Earnings growth forecast for next year|ANIP (ANI Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year MannKind Corp (MNKD)|Expected earnings per share growth for next year AMPH (Amphastar)|Projected earnings per share increase next year PCRX|ARS Pharmaceuticals - Expected earnings per share growth for next year|Expected earnings per share trend next year TBPH|Aquestive Therapeutics, Inc. - Earnings growth forecast for next year|SCPH: Net earnings per share growth forecast for next year|TECX: Earnings growth forecast for next year|TNXP - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year SXT Pharmaceuticals|Expected net earnings per share growth next year Eupraxia Pharma EPRX|Net earnings per share growth forecast for next year BioHarvest Sciences Inc. (BHST)|Expected earnings per share growth for next year Invizyne Technologies EXOZ|Earnings growth forecast for next year ORMP (Oramed Pharmaceuticals Inc.)|Entera Bio Ltd (ENTX) - Expected net earnings per share growth next year|MindWalk Holdings - Earnings growth forecast for next year|ABVC (abvcpharma.com) - Projected earnings per share growth rate for next year|CPIX: Earnings growth forecast for next year|QNTM - Consensus forecast of earnings per share growth for next year|FGEN (FibroGen Corp) - Earnings growth forecast for next year|Expected earnings per share growth for next year Telomir Pharmaceuticals Corp (TELO)|Earnings growth forecast for next year RANI|Earnings growth forecast for next year synergychc.com (SNYR)|Net earnings per share growth forecast for next year Rallybio RLYB|Lexaria Bioscience Corp - Net earnings per share growth forecast for next year|PULM: Expected earnings per share growth for next year|Expected earnings per share trend next year PTHL (Pheton Holdings Ltd)|APM: Earnings growth forecast for next year|LYRA - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year TNF Pharmaceuticals Inc.|Projected earnings per share growth rate for next year YCBD (cbdMD Corp)|Earnings growth forecast for next year PRFX|Expected earnings per share growth for next year altamiratherapeutics.com CYTO|Earnings growth forecast for next year LIPO (Lipella Pharmaceuticals)|Consensus forecast of earnings per share growth for next year optinose.com (OPTN)|Pieris Pharmaceuticals, Inc. - Earnings growth forecast for next year|PROC: Net earnings per share growth forecast for next year|Petros (PTPI) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Qilian International Corp (QLI)|Net earnings per share growth forecast for next year Acelyrin, Inc.|tffpharma.com - Net earnings per share change forecast for next year
